Hataka R. Minami

Hataka R. Minami

Auto-generated profile, based on publicly available information

Hataka R. Minami

Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2018 in Vascular Medicine
Verified
Journal Article
Open access
PDF file
NINathan K Itoga
Nathan K Itoga
HMHataka R Minami
Hataka R Minami
MCMeenadachi Chelvakumar
Meenadachi Chelvakumar
KPKeon Pearson
Keon Pearson
MMMatthew M Mell
Matthew M Mell
DODouglas K Owens
Douglas K Owens
Screening for asymptomatic peripheral artery disease (aPAD) with the ankle–brachial index (ABI) test is hypothesized to reduce disease progression and cardiovascular (CV) events by identifying individuals who may benefit from early initiation of medical therapy. Using a Markov model, we evaluated the cost effectiveness of initiating medical therapy (e.g. statin and ACE-inhibitor) after a positive ankle–brachial index (ABI) screen in 65-year-old patients. We modeled progression to symptomatic PAD (sPAD) and CV events with and without ABI screening, evaluating differences in costs and quality-adjusted life years (QALYs). The cost of the ABI test, physician visit, new medication, CV events, and interventions for sPAD were incorporated in the model. We performed sensitivity analysis on model variables with uncertainty. Our model found an incremental cost of US $338 and an incremental QALY of 0.00380 with one-time ABI screening, resulting in an incremental cost-effectiveness ratio (ICER) of $88,758/QALY over a 35-year period. The variables with the largest effects in the ICER were aPAD disease prevalence, cost of monthly medication after a positive screen and 2-year medication adherence rates. Screening high-risk populations, such as tobacco users, where the prevalence of PAD may be 2.5 times higher, decreases the ICER to $24,092/QALY. Our analysis indicates the cost effectiveness of one-time screening for aPAD depends on prevalence, medication costs, and adherence to therapies for CV disease risk reduction. Screening in higher-risk populations under favorable assumptions about medication adherence results in the most favorable cost effectiveness, but limitations in the primary data preclude definitive assessment of cost effectiveness.

11 May 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
HMHataka R. Minami
Hataka R. Minami
XLXujia Li
Xujia Li
SOSamantha K. Ong
Samantha K. Ong
SASteven Allen
Steven Allen
PAParswa Ansari
Parswa Ansari
MSMatthew R. Smeds
Matthew R. Smeds

1 May 2015 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
JLJiawen Li
Jiawen Li
HMHataka Minami
Hataka Minami
ESEarl Steward
Earl Steward
TMTeng Ma
Teng Ma
DMDilbahar Mohar
Dilbahar Mohar
Zhongping ChenZhongping Chen
Zhongping Chen
An increasing number of integrated optical and acoustic intravascular imaging systems have been developed and hold great promise for accurately diagnosing vulnerable plaques and guiding atherosclerosis treatment. However, in any intravascular environment, the vascular lumen is filled with blood, a high-scattering source for optical and high-frequency ultrasound signals. Blood must be flushed away to provide clearer images. To our knowledge, no research has been performed to find the ideal flushing agent for combined optical and acoustic imaging techniques. We selected three solutions as potential flushing agents for their image-enhancing effects: mannitol, dextran, and iohexol. Testing of these flushing agents was performed in a closed-loop circulation model and <italic<in vivo</italic< on rabbits. We found that a high concentration of dextran was the most useful for simultaneous intravascular ultrasound and optical coherence tomography imaging.

1 December 2021 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
HMHataka R. Minami
Hataka R. Minami
NINathan K. Itoga
Nathan K. Itoga
EGElizabeth L. George
Elizabeth L. George
MGManuel Garcia-Toca
Manuel Garcia-Toca

15 July 2020 in Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PDF file
HMHataka R. Minami
Hataka R. Minami
MZMark S. Zemela
Mark S. Zemela
ARAdam C. Ring
Adam C. Ring
MWMichael S. Williams
Michael S. Williams
MSMatthew R. Smeds
Matthew R. Smeds
Patients with vascular disease have higher mortality rates than age-matched peers and medical management of coexisting diseases may alter these outcomes. We sought to understand factors associated with medication nonadherence in vascular surgery patients at a single University vascular surgery clinic over a 3-month period. Consecutive vascular surgery patients were surveyed from June to August 2019. The survey included demographic questions, the validated Morisky Medication Adherence Scale, the 4-item Patient Health Questionnaire for Anxiety and Depression scales, and other medication-related questions. Medical and surgical histories were retrospectively collected from charts. Univariate and multivariate analyses were used to compare among high, intermediate, and low adherence. A total of 128 (74%) of 174 patients met study inclusion criteria. On univariate analysis, lower medication adherence was associated with younger age (P = .004), anxiety and depression (P = .001), higher daily pain (P < .001), and patients who believed their medications were less important for treating their vascular disease (P < .001). Adherence was not associated with symptomatic vascular disease, gender, education level, marital status, employment, insurance, or the use of medication usage reminders. Multivariate analysis significantly predicted high adherence relative to low adherence with 5-year increase in age (odds ratio [OR] = 1.252, P = .021) and low adherence relative to high adherence with greater perceived pain (OR = 0.839, P = .016). Younger age and high level of pain were associated with lower medication adherence. Informing patients of the importance of prescribed medication and addressing anxiety or depression symptoms may improve adherence.

4 March 2014
Verified
Conference Paper
Closed access
PDF file
JLJiawen Li
Jiawen Li
TMTeng Ma
Teng Ma
DMDilbahar Mohar
Dilbahar Mohar
ACAdrian Correa
Adrian Correa
HMHataka Minami
Hataka Minami
ZCZhongping Chen
Zhongping Chen
Intravascular ultrasound (IVUS) imaging and optical coherence tomography (OCT), two commonly used intracoronary imaging modalities, play important roles in plaque evaluation. The combined use of IVUS (to visualize the entire plaque volume) and OCT (to quantify the thickness of the plaque cap, if any) is hypothesized to increase plaque diagnostic accuracy. Our group has developed a fully-integrated dual-modality IVUS-OCT imaging system and 3.6F catheter for simultaneous IVUS-OCT imaging with a high resolution and deep penetration depth. However, the diagnostic accuracy of an integrated IVUS-OCT system has not been investigated. In this study, we imaged 175 coronary artery sites (241 regions of interest) from 20 cadavers using our previous reported integrated IVUS-OCT system. IVUS-OCT images were read by two skilled interventional cardiologists. Each region of interest was classified as either calcification, lipid pool or fibrosis. Comparing the diagnosis by cardiologists using IVUSOCT images with the diagnosis by the pathologist, we calculated the sensitivity and specificity for characterization of calcification, lipid pool or fibrosis with this integrated system. In vitro imaging of cadaver coronary specimens demonstrated the complementary nature of these two modalities for plaques classification. A higher accuracy was shown than using a single modality alone.